1. Changing views on adverse event reporting. Issue 11 (November 2018) Authors: Flores, Beatriz; Klaar, Sigrid; O'Connor, Daniel J Journal: Lancet Issue: Volume 5:Issue 11(2018) Page Start: e506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX‐351) for the Treatment of Adults with Newly Diagnosed, Therapy‐Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia‐Related Changes. (13th April 2020) Authors: Tzogani, Kyriaki; Penttilä, Karri; Lapveteläinen, Tuomo; Hemmings, Robert; Koenig, Janet; Freire, João; Márcia, Silva; Cole, Susan; Coppola, Paola; Flores, Beatriz; Barbachano, Yolanda; Roige, Silvia Domingo; Pignatti, Francesco Journal: Oncologist Issue: Volume 25:Number 9(2020) Page Start: e1414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Individual Trade‐Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma. (27th October 2017) Authors: Postmus, Douwe; Richard, Sarah; Bere, Nathalie; van Valkenhoef, Gert; Galinsky, Jayne; Low, Eric; Moulon, Isabelle; Mavris, Maria; Salmonsson, Tomas; Flores, Beatriz; Hillege, Hans; Pignatti, Francesco Journal: Oncologist Issue: Volume 23:Number 1(2018) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use. (18th April 2016) Authors: Nieto, Maria; Demolis, Pierre; Béhanzin, Eliane; Moreau, Alexandre; Hudson, Ian; Flores, Beatriz; Stemplewski, Henry; Salmonson, Tomas; Gisselbrecht, Christian; Bowen, David; Pignatti, Francesco Journal: Oncologist Issue: Volume 21:Number 6(2016) Page Start: 692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The European Medicines Agency Review of Pixantrone for the Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non‐Hodgkin's B‐Cell Lymphomas: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use. (24th April 2013) Authors: Péan, Elias; Flores, Beatriz; Hudson, Ian; Sjöberg, Jan; Dunder, Kristina; Salmonson, Tomas; Gisselbrecht, Christian; Laane, Edward; Pignatti, Francesco Journal: Oncologist Issue: Volume 18:Number 5(2013) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use. (11th February 2015) Authors: Hanaizi, Zahra; Flores, Beatriz; Hemmings, Robert; Camarero, Jorge; Sancho-Lopez, Arantxa; Salmonson, Tomas; Gisselbrecht, Christian; Laane, Edward; Pignatti, Francesco Journal: Oncologist Issue: Volume 20:Number 3(2015) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The European Medicines Agency Review of Pomalidomide in Combination With Low‐Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use. (11th February 2015) Authors: Hanaizi, Zahra; Flores, Beatriz; Hemmings, Robert; Camarero, Jorge; Sancho‐Lopez, Arantxa; Salmonson, Tomas; Gisselbrecht, Christian; Laane, Edward; Pignatti, Francesco Journal: Oncologist Issue: Volume 20:Number 3(2015) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗